Urinary Tract Infection (Uti) in Postmenopausal Women With Type 2 Diabetes Mellitus Using Sodium Glucose Co Transporter 2 Inhibitors (Sglt-2 I)

OBJECTIVE. To determine the frequency of urinary tract infection in postmenopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. MATERIAL AND METHODS. This descriptive cross-sectional study was performed on 101 postmenopausal patients with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. Samples of blood and urine were sent to the hospital laboratory for analysis. Data was analyzed using SPSS version 20. The Chi-square test was performed after stratification. RESULTS. The mean and standard deviation for age was 60.9±4.4. 24.8% of post-menopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors were having urinary tract infections. The majority of these patients were illiterate or had primary education and the duration of diabetes was more than 10 years. CONCLUSION. Urinary tract infection is a common problem in postmenopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. Patients with poorly controlled diabetes and increased duration of menopause have an increased risk of urinary tract infection. KEYWORDS. Urinary tract infection (UTI), Post-menopausal, type 2 diabetes mellitus (DM), sodium-glucose co-transporter 2 inhibitors (SGLT2Is).